Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Comment by Interpolation1on Aug 05, 2016 2:43pm
99 Views
Post# 25115013

RE:RE:RE:RE:LP's by patient count

RE:RE:RE:RE:LP's by patient countNot only do clients switch (I know some who have but the majority are brand loyal until pissed off ... so that is good) but it is the VALUE of the client too.  Veterans use 5 to 10x more per day than the average client and Aphria has a disproportionate number of Veterans.  When they announced growth of just over 700 patients last quarter some on the boards were all over that low number and I agree it needs details around it ... but if half were Veterans ... that could be 4000 or more typical patient equivalencies and shipping more product to one address is less expensive then less product to several addresses.   Now that we hit $4+ I can rest ... said it in February we would hit it in August ... not bragging as I wish I was wrong when you (I think) and others thought $10+ .... and hey, we may still get there if MMPR2.0 is what we all hope it is!   I have never wanted to be wrong so much!   :)    have a great weekend and Go Jays Go.

FalconM wrote: Gov. will clarify MMAR and MMPR regulations. A favorable ruling would be to seriously limit number of plants you can grow for personal use and allow pharmacies the ability to sell MJ from licensed producers, thereby providing greater access. Such a ruling would undermine the dispensaries which are our main competitor.


Bullboard Posts